Labiana Health, S.A. (BME:LAB)

Labiana Health Statistics

Total Valuation

Labiana Health has a market cap or net worth of EUR 33.44 million. The enterprise value is 64.68 million.

Market Cap	33.44M
Enterprise Value	64.68M

Important Dates

The next estimated earnings date is Wednesday, April 22, 2026.

Earnings Date	Apr 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Labiana Health has 7.00 million shares outstanding. The number of shares has decreased by -0.65% in one year.

Current Share Class	7.00M
Shares Outstanding	7.00M
Shares Change (YoY)	-0.65%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.59%
Float	n/a

Valuation Ratios

The trailing PE ratio is 36.97 and the forward PE ratio is 13.26.

PE Ratio	36.97
Forward PE	13.26
PS Ratio	0.47
PB Ratio	9.28
P/TBV Ratio	7.79
P/FCF Ratio	498.03
P/OCF Ratio	10.51
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.89, with an EV/FCF ratio of 963.36.

EV / Earnings	71.52
EV / Sales	0.90
EV / EBITDA	6.89
EV / EBIT	10.34
EV / FCF	963.36

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 9.98.

Current Ratio	1.42
Quick Ratio	0.86
Debt / Equity	9.98
Debt / EBITDA	3.83
Debt / FCF	535.83
Interest Coverage	1.20

Financial Efficiency

Return on equity (ROE) is 23.11% and return on invested capital (ROIC) is 10.04%.

Return on Equity (ROE)	23.11%
Return on Assets (ROA)	7.43%
Return on Invested Capital (ROIC)	10.04%
Return on Capital Employed (ROCE)	19.39%
Revenue Per Employee	181,915
Profits Per Employee	2,295
Employee Count	369
Asset Turnover	1.36
Inventory Turnover	2.64

Taxes

Income Tax	-278,386
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +139.00% in the last 52 weeks. The beta is 0.22, so Labiana Health's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	+139.00%
50-Day Moving Average	4.39
200-Day Moving Average	3.72
Relative Strength Index (RSI)	73.45
Average Volume (20 Days)	1,813

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Labiana Health had revenue of EUR 71.67 million and earned 904,362 in profits. Earnings per share was 0.13.

Revenue	71.67M
Gross Profit	40.67M
Operating Income	6.25M
Pretax Income	573,797
Net Income	904,362
EBITDA	9.38M
EBIT	6.25M
Earnings Per Share (EPS)	0.13

Balance Sheet

The company has 3.77 million in cash and 35.97 million in debt, giving a net cash position of -32.21 million or -4.60 per share.

Cash & Cash Equivalents	3.77M
Total Debt	35.97M
Net Cash	-32.21M
Net Cash Per Share	-4.60
Equity (Book Value)	3.60M
Book Value Per Share	0.65
Working Capital	9.19M

Cash Flow

In the last 12 months, operating cash flow was 3.18 million and capital expenditures -3.11 million, giving a free cash flow of 67,138.

Operating Cash Flow	3.18M
Capital Expenditures	-3.11M
Free Cash Flow	67,138
FCF Per Share	0.01

Margins

Gross margin is 56.74%, with operating and profit margins of 8.73% and 1.26%.

Gross Margin	56.74%
Operating Margin	8.73%
Pretax Margin	0.80%
Profit Margin	1.26%
EBITDA Margin	13.09%
EBIT Margin	8.73%
FCF Margin	0.09%

Dividends & Yields

Labiana Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.65%
Shareholder Yield	0.65%
Earnings Yield	2.70%
FCF Yield	0.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Labiana Health has an Altman Z-Score of 2.31 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.31
Piotroski F-Score	6